tirzepatide fda approval Tirzepatide, the new approved medication for weight loss? New weight-loss treatment becomes first

Weight reduction with GLP-1 analogues Doctors also prescribe GLP-1 receptor agonists for patients with type 2 diabetes who are unable to lose weight by conventional means

By mimicking GLP-1, this medication helps reduce appetite, promote a sense of fullness, and slow down digestion

Common Side Effects The primary side effects are gastrointestinal: Nausea: Affects 20-40% of patients, usually improving over weeks as the body adjusts

Ongoing research continues to monitor and evaluate the safety profile of semaglutide, including any potential effects on hearing. Clinical trials and post-marketing data have not identified hearing loss as a side effect of semaglutide

More serious side effects of lisinopril can include swelling of the face, lips, tongue, or throat